Catalyst Event
Gilead Sciences Inc (GILD) · Other
From KEDI Tesla Fixed Tech100 Index (KTSLT100)
4/14/2026, 12:00:00 AM
PEPFAR and The Global Fund are expected to announce an additional investment in Gilead's lenacapavir on April 14, 2026, to expand access in resource-limited countries. Low importance is estimated as revenue impact is likely under 1% expected.
Korean Translation
2026년 4월 14일 저소득 국가의 접근성 확대를 위한 PEPFAR 및 글로벌 펀드의 레나카파비르 추가 투자 발표가 있음. 매출 영향은 1% 미만일 것으로 보여 중요도를 'Low'로 예상함 예상됨.
Related Recent Events
Credo Technology Group Holding Ltd (CRDO) · Earnings Release
Q4 and Full Fiscal Year 2026 earnings release on 2026-06-01 expected. Analysts forecast EPS around $0.93 and revenue of approximately $431 million forecasted. Earnings releases typically cause 5-10% price movement.
6/1/2026, 12:00:00 AM
Marvell Technology Inc (MRVL) · Earnings Release
First quarter fiscal year 2027 earnings results are scheduled to be released on May 29, 2026. Market impact is estimated at >1% as earnings releases typically drive volatility scheduled.
5/29/2026, 12:00:00 AM
Analog Devices Inc (ADI) · Earnings Release
Analog Devices is expected to release its fiscal second quarter 2026 financial results around late May. The date is estimated based on previous reporting schedules and is scheduled.
5/28/2026, 12:00:00 AM
Axon Enterprise Inc (AXON) · Other
Axon's Annual Meeting of Shareholders on 2026-05-28 where director Matthew McBrady will not seek re-election, which is estimated to have low importance as board changes are common, is scheduled.
5/28/2026, 12:00:00 AM
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA Q1 FY2027 earnings release and conference call scheduled. Low importance is estimated as a date announcement typically has >=1% price impact.
5/27/2026, 12:00:00 AM
Synopsys Inc (SNPS) · Earnings Release
Low importance estimated as market impact is pending results; Q2 2026 earnings release is scheduled.
5/27/2026, 12:00:00 AM